MX394718B - Agresividad de control a intervalo. - Google Patents
Agresividad de control a intervalo.Info
- Publication number
- MX394718B MX394718B MX2018014680A MX2018014680A MX394718B MX 394718 B MX394718 B MX 394718B MX 2018014680 A MX2018014680 A MX 2018014680A MX 2018014680 A MX2018014680 A MX 2018014680A MX 394718 B MX394718 B MX 394718B
- Authority
- MX
- Mexico
- Prior art keywords
- computing device
- person
- glucose
- current risk
- risk metric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
- A61M2205/8212—Internal energy supply devices battery-operated with means or measures taken for minimising energy consumption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Optics & Photonics (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporcionan un método y sistema para determinar un ajuste de la tasa basal de insulina en un sistema de monitoreo continuo de glucosa de una persona con diabetes. El método incluye recibir, por al menos un dispositivo de cómputo, una señal representativa de al menos una medición de glucosa; detectar, por el al menos un dispositivo de cómputo, un estado de glucosa de la persona con base en la señal, el estado de glucosa detectado incluyendo un nivel de glucosa de la persona y una tasa de cambio del nivel de glucosa; determinar, por el al menos un dispositivo de cómputo, una métrica de riesgo actual, la métrica de riesgo actual indicando un riesgo de al menos una de una condición hipoglucémica y una condición hiperglucémica de la persona; y calcular, por el al menos un dispositivo de cómputo, un ajuste a una tasa basal de un dispositivo de administración de terapia con base en la métrica de riesgo actual y un algoritmo de control a intervalo que comprende al menos un parámetro de agresividad.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/170,450 US10332633B2 (en) | 2016-06-01 | 2016-06-01 | Control-to-range aggressiveness |
| PCT/US2017/031661 WO2017209902A1 (en) | 2016-06-01 | 2017-05-09 | Control-to-range aggressiveness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018014680A MX2018014680A (es) | 2019-04-29 |
| MX394718B true MX394718B (es) | 2025-03-24 |
Family
ID=58745386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018014680A MX394718B (es) | 2016-06-01 | 2017-05-09 | Agresividad de control a intervalo. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10332633B2 (es) |
| EP (1) | EP3465491B8 (es) |
| KR (1) | KR102428180B1 (es) |
| CN (1) | CN109564774B (es) |
| AU (1) | AU2017275392B2 (es) |
| CA (1) | CA3025906A1 (es) |
| CY (1) | CY1124983T1 (es) |
| DK (1) | DK3465491T3 (es) |
| ES (1) | ES2906640T3 (es) |
| HU (1) | HUE057491T2 (es) |
| MX (1) | MX394718B (es) |
| PL (1) | PL3465491T3 (es) |
| PT (1) | PT3465491T (es) |
| WO (1) | WO2017209902A1 (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9465917B2 (en) * | 2014-05-30 | 2016-10-11 | Roche Diabetes Care, Inc. | Hazard based assessment patterns |
| JP6853198B2 (ja) * | 2015-06-28 | 2021-03-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | 1型糖尿病に適用するための人工膵臓の速度重み付けモデル予測制御 |
| US10297350B2 (en) * | 2016-06-01 | 2019-05-21 | Roche Diabetes Care, Inc. | Risk-based control-to-range |
| EP3532958B1 (en) * | 2016-10-31 | 2024-03-27 | Novo Nordisk A/S | Systems and methods for estimating the risk of a future hypoglycemic event |
| US11497851B2 (en) * | 2017-03-31 | 2022-11-15 | Lifescan Ip Holdings, Llc | Maintaining maximum dosing limits for closed loop insulin management systems |
| CA3059985C (en) | 2017-05-05 | 2023-08-08 | Eli Lilly And Company | Closed loop control of physiological glucose |
| EP4765154A2 (en) | 2017-08-02 | 2026-06-24 | Diabeloop | Closed-loop blood glucose control systems and methods |
| JP7133625B2 (ja) | 2017-12-21 | 2022-09-08 | イーライ リリー アンド カンパニー | 生理的グルコースの閉ループ制御 |
| CN108882480B (zh) * | 2018-06-20 | 2020-06-05 | 新华网股份有限公司 | 舞台灯光和装置调节方法和系统 |
| CN112313754A (zh) | 2018-06-22 | 2021-02-02 | 伊莱利利公司 | 胰岛素和普兰林肽输送系统、方法和设备 |
| CA3188736A1 (en) * | 2018-07-26 | 2020-01-30 | Eli Lilly And Company | Systems and methods for remote prescription of medication-dosing regimens |
| FR3090315B1 (fr) * | 2018-12-21 | 2022-12-09 | Commissariat Energie Atomique | Système automatisé de régulation de la glycémie d'un patient |
| US20210100952A1 (en) * | 2019-10-04 | 2021-04-08 | Sean Brown | Systems and Methods for Treating Hypoglycemia |
| US12564677B2 (en) * | 2019-10-21 | 2026-03-03 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery response to inaccurate or missed glucose values |
| CN111150901B (zh) * | 2020-02-26 | 2020-11-27 | 苏州喜全软件科技有限公司 | 一种基于电流脉冲渗透的胰岛素泵及注射方法 |
| US11690955B2 (en) | 2020-04-23 | 2023-07-04 | Medtronic Minimed, Inc. | Continuous analyte sensor quality measures and related therapy actions for an automated therapy delivery system |
| EP4138656A1 (en) * | 2020-04-23 | 2023-03-01 | Medtronic MiniMed, Inc. | Analyte sensor quality measures and related therapy actions for an automated therapy delivery system |
| US11583631B2 (en) | 2020-04-23 | 2023-02-21 | Medtronic Minimed, Inc. | Intuitive user interface features and related functionality for a therapy delivery system |
| EP4631431A3 (en) * | 2020-05-25 | 2025-11-12 | Nihon Kohden Corporation | Physiological information acquisition device, processing device, and non-transitory computer-readable medium |
| US20220044783A1 (en) * | 2020-08-10 | 2022-02-10 | Universitat Politècnica De València (Upv) | Control Method and Artificial Pancreas for Administration of Insulin, Glucagon and Rescue Carbohydrates |
| EP3984443A1 (en) | 2020-10-13 | 2022-04-20 | Diabeloop | Computerized system for repeatedly determining a value of a control parameter of a fluid infusion system |
| US12233238B2 (en) * | 2020-11-06 | 2025-02-25 | Medtronic Minimed, Inc. | Diabetes therapy based on determination of food item |
| CN116020005B (zh) * | 2021-10-25 | 2025-11-25 | 上海移宇科技股份有限公司 | 闭环人工胰腺胰岛素输注个性化控制系统 |
| CN116020003B (zh) * | 2021-10-25 | 2025-10-31 | 上海移宇科技股份有限公司 | 闭环人工胰腺胰岛素输注控制系统 |
| WO2023070245A1 (en) * | 2021-10-25 | 2023-05-04 | Medtrum Technologies Inc. | Closed-loop artificial pancreas insulin infusion control system |
| CN116020001B (zh) * | 2021-10-25 | 2026-01-27 | 上海移宇科技股份有限公司 | 闭环人工胰腺胰岛素输注控制系统 |
| CN116020004B (zh) * | 2021-10-25 | 2025-12-23 | 上海移宇科技股份有限公司 | 闭环人工胰腺胰岛素输注控制系统 |
| CN116020002B (zh) * | 2021-10-25 | 2025-11-25 | 上海移宇科技股份有限公司 | 闭环人工胰腺胰岛素输注控制系统 |
| WO2023212007A1 (en) | 2022-04-26 | 2023-11-02 | Dexcom, Inc. | System and method for titrating basal insulin doses |
| WO2025188313A1 (en) * | 2024-03-08 | 2025-09-12 | Roche Diabetes Care, Inc. | A system and method for dynamic titration of an antidiabetic |
| WO2026136247A1 (en) * | 2024-12-16 | 2026-06-25 | Insulet Corporation | Identifying potential analyte sensor faults through interaction with amd systems |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7395158B2 (en) | 2000-05-30 | 2008-07-01 | Sensys Medical, Inc. | Method of screening for disorders of glucose metabolism |
| ES2304394T3 (es) | 2000-08-18 | 2008-10-16 | Animas Technologies Llc | Dispositivo para la prediccion de eventos hipoglucemicos. |
| AU2001291189A1 (en) | 2000-09-22 | 2002-04-02 | Knobbe, Lim And Buckingham | Method and apparatus for real-time estimation and control of pysiological parameters |
| US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US7278983B2 (en) | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
| US7291107B2 (en) | 2004-08-26 | 2007-11-06 | Roche Diagnostics Operations, Inc. | Insulin bolus recommendation system |
| US8684922B2 (en) | 2006-05-12 | 2014-04-01 | Bao Tran | Health monitoring system |
| US20080269714A1 (en) | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
| GB0719969D0 (en) | 2007-10-12 | 2007-11-21 | Cambridge Entpr Ltd | Substance monitoring and control in human or animal bodies |
| US7731659B2 (en) | 2007-10-18 | 2010-06-08 | Lifescan Scotland Limited | Method for predicting a user's future glycemic state |
| US20100262434A1 (en) | 2007-12-13 | 2010-10-14 | Shaya Steven A | Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose |
| US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
| GB2466183A (en) | 2008-12-09 | 2010-06-16 | Cambridge Entpr Ltd | Closed loop diabetes management system |
| WO2010099313A1 (en) * | 2009-02-25 | 2010-09-02 | University Of Virginia Patent Foundation | Cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery |
| EP2433235A2 (en) | 2009-05-22 | 2012-03-28 | Abbott Diabetes Care, Inc. | Safety features for integrated insulin delivery system |
| US8798934B2 (en) * | 2009-07-23 | 2014-08-05 | Abbott Diabetes Care Inc. | Real time management of data relating to physiological control of glucose levels |
| US20110071464A1 (en) | 2009-09-23 | 2011-03-24 | Medtronic Minimed, Inc. | Semi-closed loop insulin delivery |
| US8843321B2 (en) | 2010-01-26 | 2014-09-23 | Roche Diagnostics Operations, Inc. | Methods and systems for processing glucose data measured from a person having diabetes |
| US8579879B2 (en) | 2010-02-19 | 2013-11-12 | Medtronic Minimed, Inc. | Closed-loop glucose control startup |
| US8532933B2 (en) | 2010-06-18 | 2013-09-10 | Roche Diagnostics Operations, Inc. | Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers |
| US8589106B2 (en) | 2010-12-22 | 2013-11-19 | Roche Diagnostics Operations, Inc. | Calibration of a handheld diabetes managing device that receives data from a continuous glucose monitor |
| US8774889B2 (en) | 2010-12-22 | 2014-07-08 | Roche Diagnostics Operations, Inc. | Patient monitoring system with efficient pattern matching algorithm |
| US20140088392A1 (en) | 2011-02-11 | 2014-03-27 | Abbott Diabetes Care Inc. | Feedback from Cloud or HCP to Payer or Patient via Meter or Cell Phone |
| CA3175850A1 (en) | 2011-08-26 | 2013-03-07 | Stephen D. Patek | Method, system and computer readable medium for adaptive advisory control of diabetes |
| US10391242B2 (en) * | 2012-06-07 | 2019-08-27 | Medtronic Minimed, Inc. | Diabetes therapy management system for recommending bolus calculator adjustments |
| US10881339B2 (en) | 2012-06-29 | 2021-01-05 | Dexcom, Inc. | Use of sensor redundancy to detect sensor failures |
| US9623179B2 (en) | 2012-08-30 | 2017-04-18 | Medtronic Minimed, Inc. | Safeguarding techniques for a closed-loop insulin infusion system |
| US9364609B2 (en) | 2012-08-30 | 2016-06-14 | Medtronic Minimed, Inc. | Insulin on board compensation for a closed-loop insulin infusion system |
| US9504412B2 (en) | 2012-09-17 | 2016-11-29 | Lifescan, Inc. | Method and system to derive glycemic patterns from clustering of glucose data |
| US9592002B2 (en) | 2012-09-21 | 2017-03-14 | Lifescan, Inc. | Method and system to derive multiple glycemic patterns from glucose measurements during time of the day |
| US10463282B2 (en) | 2012-10-04 | 2019-11-05 | Roche Diabetes Care, Inc. | System and method for assessing risk associated with a glucose state |
| US9119528B2 (en) | 2012-10-30 | 2015-09-01 | Dexcom, Inc. | Systems and methods for providing sensitive and specific alarms |
| US10383580B2 (en) | 2012-12-31 | 2019-08-20 | Abbott Diabetes Care Inc. | Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance |
| US9351670B2 (en) | 2012-12-31 | 2016-05-31 | Abbott Diabetes Care Inc. | Glycemic risk determination based on variability of glucose levels |
| US9227014B2 (en) | 2013-02-07 | 2016-01-05 | The Board Of Trustees Of The Laland Stanford Junior University | Kalman filter based on-off switch for insulin pump |
| CN105899127B (zh) | 2013-11-14 | 2019-09-24 | 加州大学董事会 | 血糖率上升检测器:用于健康监测系统的膳食检测模块 |
| US10722650B2 (en) * | 2014-03-28 | 2020-07-28 | Roche Diabetes Care, Inc. | System and method for adjusting therapy based on risk associated with a glucose state |
| US9465917B2 (en) | 2014-05-30 | 2016-10-11 | Roche Diabetes Care, Inc. | Hazard based assessment patterns |
-
2016
- 2016-06-01 US US15/170,450 patent/US10332633B2/en active Active
-
2017
- 2017-05-09 CN CN201780049249.3A patent/CN109564774B/zh active Active
- 2017-05-09 EP EP17725002.4A patent/EP3465491B8/en active Active
- 2017-05-09 KR KR1020187037673A patent/KR102428180B1/ko active Active
- 2017-05-09 PT PT177250024T patent/PT3465491T/pt unknown
- 2017-05-09 ES ES17725002T patent/ES2906640T3/es active Active
- 2017-05-09 HU HUE17725002A patent/HUE057491T2/hu unknown
- 2017-05-09 PL PL17725002T patent/PL3465491T3/pl unknown
- 2017-05-09 MX MX2018014680A patent/MX394718B/es unknown
- 2017-05-09 AU AU2017275392A patent/AU2017275392B2/en active Active
- 2017-05-09 CA CA3025906A patent/CA3025906A1/en active Pending
- 2017-05-09 DK DK17725002.4T patent/DK3465491T3/da active
- 2017-05-09 WO PCT/US2017/031661 patent/WO2017209902A1/en not_active Ceased
-
2022
- 2022-02-11 CY CY20221100122T patent/CY1124983T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN109564774A (zh) | 2019-04-02 |
| US10332633B2 (en) | 2019-06-25 |
| BR112018074903A2 (pt) | 2019-03-06 |
| PT3465491T (pt) | 2022-02-10 |
| KR102428180B1 (ko) | 2022-08-01 |
| ES2906640T3 (es) | 2022-04-19 |
| US20170348483A1 (en) | 2017-12-07 |
| MX2018014680A (es) | 2019-04-29 |
| CA3025906A1 (en) | 2017-12-07 |
| PL3465491T3 (pl) | 2022-03-28 |
| DK3465491T3 (da) | 2022-02-21 |
| HUE057491T2 (hu) | 2022-05-28 |
| KR20190013921A (ko) | 2019-02-11 |
| AU2017275392A1 (en) | 2019-01-03 |
| AU2017275392B2 (en) | 2022-03-03 |
| WO2017209902A1 (en) | 2017-12-07 |
| CN109564774B (zh) | 2024-05-24 |
| EP3465491B8 (en) | 2022-03-02 |
| EP3465491B1 (en) | 2021-12-15 |
| EP3465491A1 (en) | 2019-04-10 |
| BR112018074903A8 (pt) | 2023-01-31 |
| CY1124983T1 (el) | 2023-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124983T1 (el) | Επιθετικοτητα ελεγχου εντος διαστηματος | |
| WO2017209903A8 (en) | Control-to-range failsafes | |
| US20220262475A1 (en) | Adaptive signal processing | |
| HK1231347A1 (zh) | 用於传感器的最佳定位的方法、系统和装置 | |
| FI3277180T3 (fi) | Järjestelmiä diabetesta sairastavalta henkilöltä mitattujen glukoositietojen analysoimiseksi | |
| RU2017113941A (ru) | Поддержка принятия решения для пациентов с диабетом | |
| RU2017130943A (ru) | Способы, системы и носимое устройство для получения множества показателей состояния здоровья | |
| WO2019140441A3 (en) | Wound sensor and diagnostics system for wound therapy applications | |
| JP2017515520A5 (es) | ||
| JP2017512581A5 (es) | ||
| RU2015129489A (ru) | Метод и система гибридного контроллера с прогнозируемой моделью контроля целевого значения и контроля диапазона для искусственной поджелудочной железы | |
| EP4233987A3 (en) | Blood treatment systems | |
| EP4523621A3 (en) | Methods and apparatus for detecting and reacting to insufficient hypoglycemia response | |
| RU2015126534A (ru) | Система и способ для оптимизирования частоты сбора данных и пороговых значений для алгоритма обнаружения ухудшения состояния | |
| RU2017100528A (ru) | Система мониторинга частоты сердечных сокращений | |
| RU2015113449A (ru) | Способ и система для указания на гликемические воздействия команд инсулиновой инфузионной помпы | |
| WO2012058337A3 (en) | Continuous analyte monitor data recording device operable in a blinded mode | |
| RU2013153099A (ru) | Устройство для использования в детекторе падения или системе обнаружения падений и способ управления таким устройством | |
| WO2010147659A3 (en) | Closed-loop glucose and/or insulin control system | |
| WO2014138925A8 (en) | Wearable computing apparatus and method | |
| RU2015145376A (ru) | Способ обнаружения падений и детектор падения | |
| ATE556651T1 (de) | Überwachung von vitalparametern eines patienten mit einem körpersensornetz | |
| CA3016158A1 (en) | Probability based controller gain | |
| HK1222349A1 (zh) | 胰岛素管理 | |
| WO2014035570A3 (en) | Safeguarding measures for a closed-loop insulin infusion system |